ChartRow logo
ChartRow
Stocks and ETFs
REGN
Regeneron Pharmaceuticals Inc.Stock · Healthcare
$654.27+$29.55 (+4.73%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

REGN monthly returns

Regeneron Pharmaceuticals Inc. has averaged 2.79% per month, positive in 50% of months. Month-by-month returns for Regeneron Pharmaceuticals Inc. (REGN) below, through July 2, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.

Average month
+2.8%
415 months
Best month
+358.9%
Feb 2000
Worst month
-59.0%
Mar 2003
Positive months
50%
of all months

Regeneron Pharmaceuticals Inc. monthly returns#

Regeneron Pharmaceuticals Inc. total return by month
MonthTotal return
Jul 2026
+4.9%
Jun 2026
+1.4%
May 2026
-12.9%
Apr 2026
-8.5%
Mar 2026
-1.2%
Feb 2026
+5.5%
Jan 2026
-3.9%
Dec 2025
-1.1%
Nov 2025
+19.9%
Oct 2025
+15.9%
Sep 2025
-3.2%
Aug 2025
+6.6%

Monthly total return (since Aug 2021)

-20%-10%+0%+10%+20%
20222023202420252026

Methodology#

Monthly returns are total returns (dividends reinvested), computed from REGN's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ

What is Regeneron Pharmaceuticals Inc.'s average monthly return?
Regeneron Pharmaceuticals Inc. (REGN) has averaged about 2.79% per month, positive in roughly 50% of months. The best month was Feb 2000 (+358.9%) and the worst was Mar 2003 (-59.0%).